Novel generation of hormone receptor specificity by amino terminal processing of peptide YY

https://doi.org/10.1016/S0006-291X(05)81547-5Get rights and content

Summary

The physiological significance of multiple Y receptors has not been determined since until recently only one form of endogenous agonists was known, namely PYY1-36 and NPY1-36. Recently, a new molecular form of PYY was characterized as des(Tyr-Pro)PYY (PYY3-36 or PYY-II). Its ability to interact at various Y receptors was not characterized. Analytical chromatography of fresh canine colon extracts shows two peaks of immunoreactivity eluting in the positions of PYY-II and PYY1-36 (PYY). PYY-II was about 40% of the total PYY immunoreactivity indicating that it is one of the major forms of PYY expressing its biological activity. It is shown that PYY-II will not displace label from the Yl receptors found on a human neuroblastoma cell line. It is further shown that PYYII is as potent as PYY for the inhibition of pancreatic secretion, which must occur through Y2 receptors. The enzymatic removal of Tyr-Pro from PYY to form PYYII must therefore regulate the relative expression of a non-selective agonist (PYY) to a highly selective Y2 agonist (PYY-II). Amino terminal processing of PYY represents a novel type of regulation of peptide hormone specificity. It has important biological implications for PYY and potential relevance for other peptide hormone receptor systems.

References (11)

  • EberleinG.A. et al.

    Peptides

    (1989)
  • EysseleinV.E. et al.

    Peptides.

    (1990)
  • BradfordM.M.

    Anal. Biochem.

    (1976)
  • WahlestedtC. et al.

    Ann. NY Acad. Sci.

    (1990)
  • TatemotoK.
There are more references available in the full text version of this article.

Cited by (0)

View full text